Trials / Completed
CompletedNCT04671953
Effect of BMS-986165 on the Blood Levels of Metformin
An Open-label, Two-arm Crossover Study to Investigate the Effect of BMS-986165 on the Pharmacokinetics of Metformin in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the effects of BMS-986165 on the drug levels of metformin in healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986165 | Specified dose on specified days |
| DRUG | Metformin | Specified dose on specified days |
Timeline
- Start date
- 2020-12-18
- Primary completion
- 2021-03-03
- Completion
- 2021-03-30
- First posted
- 2020-12-17
- Last updated
- 2021-11-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04671953. Inclusion in this directory is not an endorsement.